See more : World Houseware (Holdings) Limited (0713.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Orphazyme A/S (0CUM.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Orphazyme A/S, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Lithium Technology Corporation (LTHUQ) Income Statement Analysis – Financial Results
- NWS Holdings Limited (NWSGY) Income Statement Analysis – Financial Results
- Carlo Gavazzi Holding AG (0QL5.L) Income Statement Analysis – Financial Results
- Young Fast Optoelectronics Co., Ltd. (3622.TW) Income Statement Analysis – Financial Results
- California Style Palms, Inc. (CFPI) Income Statement Analysis – Financial Results
Orphazyme A/S (0CUM.L)
About Orphazyme A/S
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company offers heat stock proteins that focuses on the treatment of neurodegenerative diseases by harnessing the cell protective properties of the heat shock response, which protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes. Its lead candidate is the Arimoclomol, which is in clinical development for diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, and Inclusion Body Myositis. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 361.28K | 285.41K | 196.53K | 99.05K | 55.82K | 50.96K |
| General & Administrative | 12.88K | 41.24K | 83.47K | 247.25K | 50.54K | 35.13K | 31.82K | 7.70K | 8.09K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.67K | 0.00 | 0.00 |
| SG&A | 12.88K | 41.24K | 83.47K | 247.25K | 50.54K | 35.13K | 33.49K | 7.70K | 8.09K |
| Other Expenses | 14.16K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 26.83K | 41.24K | 83.47K | 621.09K | 336.83K | 232.28K | 131.04K | 63.37K | 58.92K |
| Cost & Expenses | 27.04K | 41.24K | 83.47K | 621.09K | 336.83K | 232.28K | 131.04K | 63.37K | 58.92K |
| Interest Income | 786.00 | 193.00 | 37.00 | 14.07K | 6.17K | 2.82K | 662.00 | 69.00 | 40.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 782.00 | 13.21K | 13.21K | 2.08K | 1.75K | 1.37K | 747.00 | 572.00 | 572.00 |
| EBITDA | -12.10K | -40.46K | -70.26K | -606.45K | -334.21K | -230.29K | -130.30K | -62.95K | -58.47K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -27.04K | -41.24K | -83.47K | -608.53K | -335.95K | -231.65K | -131.04K | -63.52K | -59.04K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 993.00 | 185.00 | 36.00 | -26.63K | -7.04K | -3.45K | -662.00 | 85.00 | 80.00 |
| Income Before Tax | -26.05K | -41.06K | -83.44K | -635.16K | -343.00K | -235.10K | -131.70K | -63.44K | -58.96K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 2.75K | 4.94K | 1.92K | 5.50K | 5.50K | 5.50K | 5.50K | 5.50K |
| Net Income | -26.05K | -38.31K | -78.50K | -633.25K | -337.50K | -229.60K | -126.20K | -57.94K | -53.46K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -744.23 | -1.09K | -2.31K | -22.62K | -16.87K | -11.48 | -10.43 | -5.89 | -12.70 |
| EPS Diluted | -737.65 | -1.09K | -2.25K | -22.32K | -16.85K | -11.48 | -10.43 | -5.89 | -16.59 |
| Weighted Avg Shares Out | 35.00 | 35.00 | 34.00 | 28.00 | 20.00 | 20.01K | 12.10K | 9.83K | 4.21K |
| Weighted Avg Shares Out (Dil) | 35.31 | 35.27 | 34.93 | 28.37 | 20.03 | 20.01K | 12.10K | 9.83K | 3.22K |
Source: https://incomestatements.info
Category: Stock Reports